CardioNet, headquartered in Pennsylvania, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient TelemetryTM (MCOTTM) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients–at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.  |
| Date | Title | | | 12/15/11 | CardioNet, Inc. Reaches Preliminary Agreement on Shareholders Litigation| CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dec. 15, 2011--
CardioNet, Inc. (NASDAQ: BEAT), a leading wireless medical technology
company with a current focus on the diagnosis and monitoring of cardiac
arrhythmias, today announced that it has reached a preliminary agreement
to settle the West Palm Beach Police Pension Fund putative class action
litigation that was previously disclosed in the Company’s public
filings. The preliminary agreement must be documen... |
|  | | 12/14/11 | CardioNet, Inc. Announces the Launch of its Next Generation MCOT(TM)
Device| CONSHOHOCKEN, Pa., Dec 14, 2011 (BUSINESS WIRE) --CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology
company with a current focus on the diagnosis and monitoring of cardiac
arrhythmias, today announced the launch of its next generation Mobile
Cardiac Outpatient Telemetry device.
Joseph Capper, President and Chief Executive Officer of CardioNet,
commented: "The launch of this state-of-the-art system is further
evidence of our commitment... |
| | | 12/14/11 | CardioNet, Inc. Announces the Launch of its Next Generation MCOT™ Device| CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dec. 14, 2011--
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology
company with a current focus on the diagnosis and monitoring of cardiac
arrhythmias, today announced the launch of its next generation Mobile
Cardiac Outpatient Telemetry device.
Joseph Capper, President and Chief Executive Officer of CardioNet,
commented: “The launch of this state-of-the-art system is further
eviden... |
| | | 11/08/11 | CardioNet, Inc. Reports Third Quarter 2011 Financial Results| CONSHOHOCKEN, Pa., Nov 08, 2011 (BUSINESS WIRE) -- CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2011.
Third Quarter 2011 and Recent Highlights
Achieved positive adjusted EBITDA year to date
Biotel contributed positive EBITDA and is on track to exceed our expectations
Improved GAAP and adjusted operating loss as a ... |
| |
|
|
|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
| |
| | EMAIL ALERTS | Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now! |
|
|
